Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.

Heslegrave A, Heywood W, Paterson R, Magdalinou N, Svensson J, Johansson P, Öhrfelt A, Blennow K, Hardy J, Schott J, Mills K, Zetterberg H. · 2016

Read Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease. by Heslegrave A, Heywood W, Paterson R, Magdalinou N, Svensson J, Johansson P, Öhrfelt A, Blennow K, Hardy J, Schott J, Mills K, Zetterberg H. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4709982.txt.

Description

Amanda Heslegrave, Wendy Heywood, Ross Paterson, and nine colleagues measured a microglia protein fragment in spinal fluid in Molecular Neurodegeneration in 2016. The protein TREM2 sits on microglia, the brain's immune cells, and rare faults in its gene raise Alzheimer's risk sharply. A soluble piece of it, sTREM2, can be measured in cerebrospinal fluid, but commercial test kits proved unreliable in the team's hands. They built a mass spectrometry method to measure it exactly.

Spinal fluid from Alzheimer's patients carried more sTREM2 than fluid from healthy controls, in two separate clinic groups. Levels also tracked with tau markers of nerve damage. The authors read the rise as a sign of glial activation in the disease. A dependable measure of sTREM2, they argue, could help track the brain's immune side of Alzheimer's, a side that genetics keeps pointing at but trials struggle to follow.

Catalog record

CREATORHeslegrave A, Heywood W, Paterson R, Magdalinou N, Svensson J, Johansson P, Öhrfelt A, Blennow K, Hardy J, Schott J, Mills K, Zetterberg H.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4709982

Browse the full library · About the Tower of Babel